Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Arndt

Showing results (301-310 of 311) with videos related to

Pageof 32
Sort By:
Cancers|April 3, 2021
Doxorubicin-Loaded Gold Nanoarchitectures as a Therapeutic Strategy against Diffuse Intrinsic Pontine GliomaCaitlin Ung, Maria Tsoli, Jie Liu, et al.
British Journal of Cancer|January 11, 2020
Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapyAlvin Kamili, Andrew J Gifford, Nancy Li, et al.
Leukemia|July 23, 2016
Systematic chemical and molecular profiling of MLL-rearranged infant acute lymphoblastic leukemia reveals efficacy of romidepsinM N Cruickshank, J Ford, L C Cheung, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 13, 2024
FDA-approved disulfiram as a novel treatment for aggressive leukemiaMawar Karsa, Lin Xiao, Emma Ronca, et al.
Ebiomedicine|August 12, 2023
Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergismsJérémy Ariey-Bonnet, Raphael Berges, Marie-Pierre Montero, et al.
Frontiers in Oncology|June 9, 2022
The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia ProgressionLin Xiao, Mawar Karsa, Emma Ronca, et al.
Cancer Cytopathology|May 27, 2021
The important role of routine cytopathology in pediatric precision oncologyJinhan Xie, Amit Kumar, M Emmy M Dolman, et al.
Oncogene|March 4, 2021
A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastomaBelamy B Cheung, Ane Kleynhans, Rituparna Mittra, et al.
Blood|December 9, 2022
Contribution of mutant HSC clones to immature and mature cells in MDS and CMML, and variations with AZA therapyAnnatina S Schnegg-Kaufmann, Julie A I Thoms, Golam Sarower Bhuyan, et al.
Cancer Research|July 31, 2023
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk CancerChelsea Mayoh, Jie Mao, Jinhan Xie, et al.
Pageof 32

Showing results (301-310 of 311) with videos related to

Sort By:
Pageof 32
Cancers|April 3, 2021
Doxorubicin-Loaded Gold Nanoarchitectures as a Therapeutic Strategy against Diffuse Intrinsic Pontine GliomaCaitlin Ung, Maria Tsoli, Jie Liu, et al.
British Journal of Cancer|January 11, 2020
Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapyAlvin Kamili, Andrew J Gifford, Nancy Li, et al.
Leukemia|July 23, 2016
Systematic chemical and molecular profiling of MLL-rearranged infant acute lymphoblastic leukemia reveals efficacy of romidepsinM N Cruickshank, J Ford, L C Cheung, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 13, 2024
FDA-approved disulfiram as a novel treatment for aggressive leukemiaMawar Karsa, Lin Xiao, Emma Ronca, et al.
Ebiomedicine|August 12, 2023
Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergismsJérémy Ariey-Bonnet, Raphael Berges, Marie-Pierre Montero, et al.
Frontiers in Oncology|June 9, 2022
The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia ProgressionLin Xiao, Mawar Karsa, Emma Ronca, et al.
Cancer Cytopathology|May 27, 2021
The important role of routine cytopathology in pediatric precision oncologyJinhan Xie, Amit Kumar, M Emmy M Dolman, et al.
Oncogene|March 4, 2021
A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastomaBelamy B Cheung, Ane Kleynhans, Rituparna Mittra, et al.
Blood|December 9, 2022
Contribution of mutant HSC clones to immature and mature cells in MDS and CMML, and variations with AZA therapyAnnatina S Schnegg-Kaufmann, Julie A I Thoms, Golam Sarower Bhuyan, et al.
Cancer Research|July 31, 2023
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk CancerChelsea Mayoh, Jie Mao, Jinhan Xie, et al.
Pageof 32